Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range

January 5, 2011 By Bio-Medicine.Org

BEIJING, Jan. 6, 2011 /PRNewswire-Asia/ — Sinovac Biotech Ltd.
(Nasdaq:
SVA
), a leading provider of biopharmaceutical products in
China, announced today its preliminary unaudited sales range for
the fourth quarter and full year ended December 31, 2010. A
conference call to discuss these preliminary sales will be held on
January 6, 2011 at 8:00 a.m. Eastern Standard Time (January 6, 2011
at 9:00 pm China Standard Time). The Company will issue its final
unaudited fourth quarter and full year 2010 financial results on or
about March 31, 2011.

Sinovac expects its fourth quarter 2010 preliminary unaudited
sales to be in the range of approximately $7.8 million to $10.8
million and its full year 2010 preliminary unaudited sales to be in
the range of $32 million to $35 million.  The shortfall in
sales as compared to the revised total 2010 sales expectations
issued in October 2010 was attributable to the weaker than expected
sales of Anflu and Healive in the private market.

Dr. Weidong Yin, Chairman & CEO, commented, “We faced a
challenging external market environment in 2010, which negatively
impacted vaccine demand in the private market. As the company
grows, we cannot avoid market-related volatility. We believe it is
a great experience for Sinovac’s fast-growing management team to
learn and grow. Recognizing the importance of addressing this
market situation, we are undertaking initiatives to adjust our
sales strategy. Concurrently, we are continuing to advance our
R&D projects with the aim of completing development and
launching our new products. Currently, we have sufficient cash on
hand to support Company’s R&D activities, capacity expansion,
potential M&A and international collaborations, which are the
company’s driving forces for future growth.”

The preliminary sales ranges are preliminary unaudited estimates
for the fourth quarter and full y

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech